FRA:YB3'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.28 Med: 1.85 Max: 4.91
Current: 4.57
During the past 13 years, the highest Dividend Yield of Shin Nippon Biomedical Laboratories was 4.91%. The lowest was 0.28%. And the median was 1.85%.
FRA:YB3's Dividend Yield % is ranked better than 83.08% of 65
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96
vs FRA:YB3: 4.57
During the past 13 years, the highest Dividend Payout Ratio of Shin Nippon Biomedical Laboratories was 0.43. The lowest was 0.06. And the median was 0.24.
During the past 5 years, the average Dividends Per Share Growth Rate was 45.20% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shin Nippon Biomedical Laboratories was 115.40% per year. The lowest was 0.00% per year. And the median was 18.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:YB3 vs TMO, DHR, IDXX: Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shin Nippon Biomedical Laboratories Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Shin Nippon Biomedical Laboratories's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Shin Nippon Biomedical Laboratories Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 30.000000
2026-03-30
2026-03-31
2026-06-29
Cash Dividend
semi-annually
JPY:EUR 0.005438
JPY 20.000000
2025-09-29
2025-09-30
2025-11-28
Cash Dividend
semi-annually
JPY:EUR 0.005758
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shin Nippon Biomedical Laboratories (FRA:YB3) has a Dividend Yield % of 4.57% as of Jun. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Shin Nippon Biomedical Laboratories and its competitors. This is 147% above median its historical median of 1.85. Over the past decade, Shin Nippon Biomedical Laboratories' Dividend Yield % has ranged from 0.28 to 4.91. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #11 out of 65 companies in the Medical Diagnostics & Research industry, placing it in the top 16.9%.
Is Shin Nippon Biomedical Laboratories' Dividend Yield % too high?
Shin Nippon Biomedical Laboratories' current Dividend Yield % of 4.57% is 147% above median its 10-year median of 1.85. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 4.91. The Medical Diagnostics & Research industry median Dividend Yield % is 1.96. Shin Nippon Biomedical Laboratories' value of 4.57% is 133.2% above this industry median. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #11 out of 65 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #11 out of 65 companies for Dividend Yield %. This places Shin Nippon Biomedical Laboratories in the top 17% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.96. Shin Nippon Biomedical Laboratories' value of 4.57% is 133.2% above this benchmark. Historically, Shin Nippon Biomedical Laboratories' own Dividend Yield % has ranged from 0.28 to 4.91 over the past decade. While the company's 10-year median is 1.85 vs. the industry median of 1.96, Shin Nippon Biomedical Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Diagnostics & Research company?
The median Dividend Yield % among Medical Diagnostics & Research companies is 1.96, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shin Nippon Biomedical Laboratories's current Dividend Yield % of 4.57% is 133.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Shin Nippon Biomedical Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Yield % is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shin Nippon Biomedical Laboratories's current Dividend Yield % is 4.57%, which is 147% above median its own 10-year median of 1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (FRA:YB3) has a current Dividend Yield % of 4.57%. The stock's GF Value™ is €9.47, compared to a current price of €6.00 — trading 36.6% below its estimated fair value. The current Dividend Yield % is 4.57%, which is 147% above median its 10-year median of 1.85 and 133.2% above the Medical Diagnostics & Research industry median of 1.96. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (FRA:YB3), the current Dividend Yield % is 4.57% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shin Nippon Biomedical Laboratories (FRA:YB3) Overvalued in 2026?
Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued.
The current stock price of €6.00 is trading 36.6% below its estimated GF Value™ of €9.47.
Key valuation signals for FRA:YB3:
Dividend Yield %: 4.57% (147% above median its 10-year median of 1.85)
GF Value™: €9.47 vs. price of €6.00 (36.6% below fair value)
Industry Position: 133.2% above the Medical Diagnostics & Research median (#11 of 65)
No single metric tells the full story. See the FRA:YB3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shin Nippon Biomedical Laboratories Business Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score
Get the complete analysis for FRA:YB3
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:YB3 has been successfully added to your 
